NEW YORK (GenomeWeb News) — Evotec Technologies has sold the “core” of its single molecule detection technology and transferred or licensed the related IP to Olympus, the company said today.
 
The move is in line with the Evotec division’s goal of focusing its business more on cell imaging and cell handling systems, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.